Jacob Asset Management of New York’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Jacob Asset Management of New York’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$545K	Sell	44,027 -1,600	-4%	-$22.1K	0.67%	49
2013 Q2	$609K	Buy	+45,627	New	+$587K	0.82%	42

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jacob Asset Management of New York's DSCI Position: Q3 2013 in Review

Jacob Asset Management of New York reduced its Derma Sciences, Inc. Common Stock (DE) (DSCI) stake by 3.5% in Q3 2013, selling an estimated $22.1K and leaving 44,027 shares worth $545K. The position accounts for 0.67% of the portfolio, ranked #49.

Jacob Asset Management of New York first reported a position in DSCI in Q2 2013 and has held it in 2 quarters since. The position peaked at $609K in Q2 2013. 52 funds tracked by Wall St. Rank hold DSCI as of Q3 2013.

Jacob Asset Management of New York held 44,027 shares of Derma Sciences, Inc. Common Stock (DE) worth $545K as of Q3 2013.
Jacob Asset Management of New York sold 1,600 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2013, an estimated $22.1K.
Derma Sciences, Inc. Common Stock (DE) made up 0.67% of Jacob Asset Management of New York's portfolio in Q3 2013, its #49 holding.
Jacob Asset Management of New York first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and has held it in 2 quarters since.
Jacob Asset Management of New York's Derma Sciences, Inc. Common Stock (DE) position peaked at $609K in Q2 2013.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2013.

Based on Jacob Asset Management of New York's 13F filing for Q3 2013, filed 14 Nov 2013.